Page contents Back to list Full notification Final report General information GMO characterization European Commission administrative Information Return to search
Full notification Final report - General information Notification Number B/AT/22/01 Member State to which the notification was sent Austria Date of acknowledgement from the Member State Competent Authority 28/06/2022 Title of the Project Multicenter Phase II trial of MB-CART2019.1 for the Treatment of Patients with relapsed/refractory DLBCL Proposed period of release: 01/07/2022 to 30/09/2025 Name of the Institute(s) or Company(ies) Universitätsklinikum AKH Wien, 1090 Wien, Währinger-Gürtel 18-20, Austria
Is the same GMO been notified elsewhere by the same notifier? No Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: Other Identity of the GMO: T cells transduced with a replication-deficient lentiviral vector harbouring the chimeric antigen receptor for targeting CD20 and CD19.  Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Human Genus: Species: Subspecies: Strain: Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Not known
Close
Select your language
English